Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$82.7M Sell
591,927
-171,578
-22% -$21.7M 3.06% 3
2026
Q1
$82.2M Sell
763,505
-158,474
-17% -$17.8M 2.74% 6
2025
Q4
$104M Buy
921,979
+141,815
+18% +$13.5M 3.33% 6
2025
Q3
$63.6M Buy
780,164
+176,750
+29% +$16.2M 1.89% 16
2025
Q2
$62.3M Sell
603,414
-21,021
-3% -$1.97M 2.13% 19
2025
Q1
$61.5M Buy
624,435
+335,559
+116% +$44.8M 2.16% 17
2024
Q4
$43.3M Sell
288,876
-22,740
-7% -$3.13M 1.28% 32
2024
Q3
$40.6M Sell
311,616
-184,960
-37% -$23M 1.15% 37
2024
Q2
$58.8M Buy
496,576
+45,900
+10% +$4.87M 1.84% 21
2024
Q1
$42.5M Buy
450,676
+207,916
+86% +$18.6M 1.37% 30
2023
Q4
$19.3M Sell
242,760
-453,032
-65% -$30.9M 0.71% 41
2023
Q3
$52.4M Sell
695,792
-348,600
-33% -$26M 1.65% 16
2023
Q2
$74.4M Sell
1,044,392
-762,259
-42% -$43.8M 2.43% 12
2023
Q1
$90.5M Buy
1,806,651
+144,800
+9% +$7.03M 2.99% 8
2022
Q4
$72.6M Buy
+1,661,851
New +$82M 2.43% 7

Other funds holding GKOS

Braidwell's GKOS Position: Q2 2026 in Review

Braidwell reduced its Glaukos (GKOS) stake by 22% in Q2 2026, selling an estimated $21.7M and leaving 591,927 shares worth $82.7M. The position accounts for 3.06% of the portfolio, ranked #3.

Braidwell first reported a position in GKOS in Q4 2022 and has held it in 15 quarters since. The position peaked at $104M in Q4 2025. 365 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • Braidwell held 591,927 shares of Glaukos worth $82.7M as of Q2 2026.
  • Braidwell sold 171,578 Glaukos shares in Q2 2026, an estimated $21.7M.
  • Glaukos made up 3.06% of Braidwell's portfolio in Q2 2026, its #3 holding.
  • Braidwell first reported a position in Glaukos in Q4 2022 and has held it in 15 quarters since.
  • Braidwell's Glaukos position peaked at $104M in Q4 2025.
  • 365 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.